Related Experiment Video
Updated: Jun 9, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Miao Sour Soup Modulates Hepatic Gluconeogenesis Through PI3K/Akt/Foxo1 Signaling in High-Fat Diet-Induced Rats
Xue Ao1,2, Xiaoying Liu1,2, Qin Yuan1
1School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education Guizhou Medical University Guiyang China.
Abstract:
Miao Sour Soup (MSS) is a traditional fermented dish containing bioactive constituents such as lycopene, capsaicin, and short-chain fatty acids, which have been associated with anti-obesity, anti-inflammatory, and antioxidant effects. Excessively elevated hepatic gluconeogenesis is a critical element instigating energy metabolism dysregulation in the body. This research examined the extent to which MSS enhances energy metabolism abnormalities caused by a high-fat diet via hepatic gluconeogenesis and confirmed this route. The findings indicated that MSS intervention markedly decreased hepatic lipid accumulation, pro-inflammatory cytokine secretion, and blood lipid and glucose levels in rats subjected to a high-fat diet. Non-targeted metabolomics study revealed that MSS influences energy metabolism pathways, including glycolysis and gluconeogenesis. Subsequently, Western blot analysis was conducted to assess protein expression in the NF-κB inflammatory pathway and the PI3K/Akt/Foxo1 signaling pathway. The findings indicated that MSS decreased NF-κB expression in the livers of rats subjected to a high-fat diet, thereby activating the PI3K/Akt/Foxo1 signaling pathway and decreasing the expression of PEPCK and G6PC, essential proteins in gluconeogenesis. This study's results demonstrate that Foxo1 is a crucial protein in the dysregulation of glucose metabolism caused by lipid metabolism diseases. MSS may stimulate the PI3K/Akt/Foxo1 signaling pathway by mitigating chronic inflammation caused by a high-fat diet, therefore inhibiting excessive hepatic gluconeogenesis and ultimately improving insulin resistance.